I guess what happened with Yorkville will remain a mystery.
He teases the intention to move valve-in-valve to humans in the "near term". I'd expect that the FDA will at least need full 3 month EFS safety data to proceed with those procedures if they are to be done in the US but he says he's not sure where that will happen. Also seemed to allude to the Yale study. Onward and upward.
New proactive vid, page-2
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
-0.190(1.56%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $12.00 | $13.06 | $11.75 | $459.6K | 38.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5792 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.70 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |